Clinical
Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Research
Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Become a Partner
Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP Technology. Click here to start the conversation now.
Luminex Blog
Coming Soon: A New Multiplex Serology Test for SARS-CoV-2
Luminex Partner Tetracore designed a serology assay for SARS-CoV-2 using xMAP® Technology.
A new multiplex serology test to determine whether someone has been exposed to the SARS-CoV-2 virus is coming soon, thanks to assay developer Tetracore. The company—one of Luminex’s research partners—developed this test based on our xMAP Technology. We spoke with Tetracore Senior Scientist Neeraja Venkateswaran to learn more about the test and how it can help fight the COVID-19 pandemic.
Continue
Reading >
Workflow for the ARIES® SARS-CoV-2 Assay (EUA)
ARIES® SARS CoV 2 Assay Workflow (EUA)
Clinical Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.Read More Research Our xMAP® Technology and its flexiblDesigned for use on the ARIES® System, the ARIES® SARS-CoV- 2 Assay is a moderate-complexity, sample-to-answer test that enables targeted SARS-CoV-2 detection. ARIES® consolidates the assay steps into a single workflow and reduces turnaround time with STAT and random batch testing.
Watch more videos >